Medical Letter on the CDC & FDA articles from September 2004

Medical Letter on the CDC & FDA archives from September 2004

Mass media campaigns effective for reducing alcohol-involved crashes.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Mass media campaigns are effective for reducing alcohol-involved automobile crashes. According to published research from the United States, "A systematic review of the effectiveness of mass media...

Diabetes increases cancer mortality risk for some cancer types.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Diabetes increases the risk of cancer mortality for some types of cancer. According to recent research from the United States, "Several studies have suggested that diabetes mellitus may alter the...

Antimicrobial drug delivery in food animals reviewed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists review antimicrobial drug delivery in food animals and microbial food safety concerns in a recent issue of Advanced Drug Delivery Reviews. "This review provides an overview of...

American Indians and Alaska natives surveilled for HIV/AIDS and risk behaviors.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers report on results of a surveillance systems monitoring HIV/AIDS and HIV risk behaviors among American Indians and Alaska natives in a recent issue of AIDS Education and Prevention. ...

Retrospective of re-infection of humans with Plasmodium published.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists have published a retrospective examination of re-infection of humans with Plasmodium vivax in a recent issue of the American Journal of Tropical Medicine and Hygiene. According to a...

Malnutrition increases risk of acquired immunodeficiency syndrome.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Malnutrition increases risk of acquired immunodeficiency syndrome. According to recent research from the United States, "Infectious diseases are the major causes of death and morbidity in...

DNA prime-MVA boost HIV vaccine tailored for eastern and central Africa.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers have developed a DNA prime-MVA boost HIV vaccine tailored for eastern and central Africa. According to a study from England, "For the development of human immunodeficiency virus type 1...

Buprenorphine for treatment of opiate dependence reviewed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A researcher reviews buprenorphine for the treatment of opiate dependence in a recent issue of the Journal of Psychoactive Drugs. According to a study from the United States, "Buprenorphine's...

FDA approves Campral Delayed-Release Tablets for treating alcohol dependence.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) and Merck, KGaA, (Merck) of Darmstadt, Germany, announced the United States Food and Drug Administration (FDA) has approved Campral (acamprosate calcium) Delayed-Release...

Quaternary ammonium compounds exhibit adjuvant effect in murine model.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Quaternary ammonium compounds exhibit an adjuvant effect in a murine model. "It has been suggested that occupational exposure to quaternary ammonium compounds (QACs) may promote the development of...

Transgenic animal models of Alzheimer disease reviewed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers review transgenic animal models of Alzheimer disease and related disorders in a recent issue of Molecular Psychiatry. "Alzheimer disease (AD) is a devastating neurodegenerative disease...

Trial of Ranexa initiated for certain patients with chronic angina.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., (CVTX) announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a...

Inflammatory cytokines referee angiogenic control during inflammation.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Inflammatory cytokines referee angiogenic control during inflammation. "Vigorous inflammatory responses are associated with tissue damage, particularly when toxic levels of inflammatory cytokines...

Induction of metallothionein requires transcription factor and zinc.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc. "Phenolic antioxidants, such as tBHQ...

Scientists warn about pandemic potential of lesser-known bird flu strain.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A lesser-known strain of bird flu common among poultry in Asia is becoming deadlier and could set off a pandemic by mixing with human viruses, a Hong Kong scientist warns. The H9N2 strain of bird...

Nebraska proposes 10-state bioterrorism alliance.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Nebraska will use federal funding to work on developing a 10-state regional alliance to provide mutual aid in the event of bioterrorism or other public health emergencies, Governor Mike Johanns...

Company introduces enhanced red cell collection technology.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Haemonetics Corp. introduced an enhancement to its leukocytes-reduced red cell collection technology that, according to the company, triples the time within which donated blood can be filtered to remove...

Novel method developed to quantify botulinum neurotoxin antibodies.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists have applied an in vitro technique to achieve the detection and quantification of botulinum neurotoxin antibodies. According to a study from England, "Detection of Clostridium botulinum...

Orphan drug designation granted from U.S. FDA for Efaproxyn.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics (ALTH) announced that the U.S. Food and Drug Administration (FDA) awarded orphan drug status to the company's lead clinical candidate, Efaproxyn (efaproxiral) for use as an adjunct to...

7-year deflation rate data filed for breast implants post approval survey study.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- INAMED Corporation (IMDC) has filed 7-year deflation rate follow-up data with the U.S. Food and Drug Administration (FDA) for augmentation and reconstruction patients who are participating in the core...

Public beliefs about breastfeeding policies in various settings.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers outline public beliefs about breastfeeding policies in various settings in a recent issue of the Journal of the American Dietetic Association. According to a study from the United...

Company reports $8.8M Q2 loss, provides clinical update.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced results for the second quarter ended June 30, 2004. The company also highlighted its progress in development programs using its proprietary eligen...

Generics producer granted rights for fluconazole, intends to file antiretroviral.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Ranbaxy Laboratories Limited (RLL) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Fluconazole Tablets and Oral Suspension....

Antibody-targeted radiation cancer therapy reviewed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists review antibody-targeted radiation cancer therapy in a recent issue of Nature Reviews Drug Discovery. According to a study from the United States, "Several monoclonal antibodies are now...

Mesothelin is new target for immunotherapy of mesotheliomas.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Mesothelin is a new target for immunotherapy of mesotheliomas. According to a study from the United States, "Mesothelin is a differentiation antigen present on normal mesothelial cells and...

Viral chemokine fusions trigger antitumor immunity independent of chemotaxis.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. "The ideal vaccine carrier should be able to target antigen...

FDA approves Lipitor to lower risk of heart attacks.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., reported the U.S. Food and Drug Administration (FDA) has approved its cholesterol-lowering therapy Lipitor (atorvastatin calcium) for the prevention of cardiovascular disease by reducing...

Pre-IND meeting held with FDA for platelet aggregation inhibitor.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc., (ISPH) announced that a pre-Investigational New Drug (IND) meeting was held on July 29 with the U.S. Food and Drug Administration for INS50589 Cardiovascular. This...

Varicella vaccine reduces contagiousness of chickenpox.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Children and adolescents who have received the varicella (chickenpox) vaccine and contract varicella are about half as contagious as those who have not been vaccinated, according to a new study. ...

V. cholerae polysaccharide fragments are immunogenic in mice.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Synthetic fragments of Vibrio cholerae O1 inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies. According to a study from the...

Clinic's participation in colon cancer drug study provides access to new therapy.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Ocala Oncology Center, an affiliate of U.S. Oncology, Inc., (Nasdaq:USON), is bringing patients in the community a cutting-edge colon cancer therapy that in clinical trials has shown to be effective in...

FDA approves Cymbalta for the treatment of depression.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Co. (LLY) announced. ...

Physician notification program launched for kids on antidepressants.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- On March 22, 2004, the U.S. Food and Drug Administration (FDA) issued a Public Health Advisory regarding the possible worsening of depression and suicidal thoughts in adults and children taking...

Millions of American Indians, Alaska Natives at risk for type 2 diabetes.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- About 40% of adults ages 40-74 - or 41 million people - have pre-diabetes, a condition that raises a person's risk of developing type 2 diabetes, heart disease and stroke. American Indians and Alaska...

Company launches FDA-cleared high sensitivity Troponin I assay.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Dade Behring (DADE) announced its Stratus CS Cardiac Troponin I assay is the first Troponin test cleared by the U.S. Food and Drug Administration as high sensitivity. This high sensitivity...

FDA provides clearance for MAGNETOM C!
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has provided 510(k) clearance for the world's first magnetic resonance imaging (MRI) system with 270 degrees accessibility. Developed by Siemens Medical...

Monocyte activation test for parenteral drug contaminants developed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers have developed a monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs. "An optimized test designed for an in vitro monocyte activation test for...

U.S. FDA clearance given for herpes simplex virus assay.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Trinity Biotech plc (TRIB) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Captia HSV IgG Type Specific ELISAs in the United States. These...

Mothers misunderstand questions on feeding questionnaire.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Mothers misunderstand questions on a feeding questionnaire. According to published research from the United States, "Feeding questionnaires have not consistently identified mothers' beliefs or...

Biopharmaceutical company initiates clinical trial of TRX4 for psoriasis.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- TolerRx, Inc., a biopharmaceutical company, announced the initiation of a phase 1 trial of its TRX4 monoclonal antibody in subjects with psoriasis. This phase 1 trial will be a single-dose,...

Orphan drug designation granted for key component in liver assist program.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Vital Therapies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the use of immortalized human liver cells to treat fulminant hepatic...

U.S. FDA approves new drug application for generic topical cortisone ointment.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Taro Pharmaceutical Industries Ltd. (TARO) reported that its U.S. affiliate has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...

U.S. FDA grants orphan drug designation for pulmonary arterial hypertension drug.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Myogen, Inc. (MYOG), a biopharmaceutical company, announced that the U. S. Food and Drug Administration (FDA) has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial...

Drug companies approach brand security issue head on, study shows.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A recent U.S. Food and Drug Administration report cited that about 10% of all drugs worldwide are counterfeit. That can mean huge revenue losses, as much as $2 billion annually, for even a mid-sized...

WHO announces end of Ebola outbreak in southern Sudan.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The World Health Organization (WHO) has declared that an outbreak of Ebola hemorrhagic fever in southern Sudan is over. "The rapid containment of this outbreak was a tremendous success for the...

Methylprednisolone Sodium Succinate approved by FDA.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APP, APPX) announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for...

EPA orders end to 'wet method' asbestos removal at airport project.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The U.S. Environmental Protection Agency issued an order barring use of the so-called "wet method" to remove asbestos from buildings being demolished to make way for a new runway at Lambert Airport. ...

Disagreements over fluoridation of public water still strong after 50 years.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- It doesn't take but a few minutes inside Wesley Trollope's home before he might offer his visitors a glass of ice water - without added fluoride that is. Trollope, 76, has spent more than 40 years...

Tobacco industry attempted to influence reporting on secondhand smoke.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A study based on the tobacco industry's own documents shows the extent of the tobacco industry's efforts to influence the print media on the health effects of secondhand smoke. This study was...

New hope for children with fetal alcohol syndrome.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Research by University of Washington (UW) Professor Ann Streissguth shows that people diagnosed with either fetal alcohol syndrome (FAS) or fetal alcohol effect (FAE) are more likely to escape social...

Oncology-focused biopharma reports record product revenues Q2 2004.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Cytogen Corp. sshearer@cytogen.com Cytogen Corp. (CYTO), a product-driven, oncology-focused biopharmaceutical company, reported its consolidated financial results for the second quarter and 6...

Pharmaceutical company reports second quarter results.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) announced consolidated financial results for the 3 and 6 months ended June 30, 2004. The company's net loss for the 3 months ended June 30, 2004,...

Tuberculosis prevalence rates in China fall after DOTS introduced by WHO.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- An analysis of a decade-long tuberculosis (TB) program in China shows that prevalence rates of the disease have fallen substantially since the introduction of the TB control strategy known as DOTS to...

Ariol 2.0 launched as next-generation cellular imaging system.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. (AICX) announced the release of Ariol 2.0, the latest generation of its Ariol imaging analysis system. Ariol 2.0 combines screening for genetic abnormalities and protein...

Scientists announce breakthrough in pathway engineering.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists from SLAC (Stanford Linear Accelerator Center) and Genencor International, Inc., (GCOR) announced a breakthrough in the ability to compute, in record time, all possible metabolic behaviors...

Study examines inappropriate medication prescribing for elderly patients.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Prescribing of inappropriate medications for elderly patients appears relatively common, according to a new study. People 65 years or older make up less than 15% of the population, but make up...

Approvable letter issued by FDA for Lumigan.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Allergan, Inc., (AGN) announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for its Lumigan timolol combination product for glaucoma (bimatoprost 0.03%/timolol 0.05%...

HSV-2 infection increases risk of HIV transmission.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- HSV-2 infection increases risk of HIV transmission. According to a study from the United States, "The synergistic relationship between herpes simplex virus type 2 (HSV-2) and transmission of human...

Condom use reduces rate of new HIV infections in Thailand.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Researchers describe Thailand's response to the HIV epidemic in a recent issue of AIDS Education and Prevention. "Thailand's comprehensive national response to the HIV/AIDS epidemic has been...

HIV prevention drug gets U.S. FDA clearance to advance in phase 1 clinical trial.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Starpharma Holdings Limited (SPL) announced that VivaGel, its new drug for the prevention of HIV, is advancing to the next stage of dosing in the current phase 1 study. The U.S. Food and Drug...

Noninfectious X4 but not R5 HIV-1 inhibits lymphoid tissue antibody response.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Noninfectious X4 but not R5 HIV-1 virions inhibit lymphoid tissue antibody response. According to recent research published in the Journal of Virology, "Ex vivo human immunodeficiency virus type 1...

Comprehensive strategy needed to access antiretroviral treatment in South Africa.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A comprehensive strategy is needed to access antiretroviral treatment in South Africa. According to recent research published in the journal Lancet, "Malawi, Mozambique, Swaziland, and South Africa...

FDA approves Sculptra (injectable poly-L-lactic acid).
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Dermik Laboratories, the U.S. dermatology arm of Aventis (AVE), announced the U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid) as the only product for the...

FDA approves two fixed-dose combination drug products for HIV-1 infection.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1...

U.S. FDA approves Truvada as part of HIV combination therapy.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Gilead Sciences (GILD) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Truvada (emtricitabine and tenofovir disoproxil fumarate) a fixed-dose combination...

US$5-6 billion needed by 2005 to provide ART to low-, middle-income countries.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- US$5-6 billion is needed by the end of 2005 to provide antiretroviral therapy to low-/middle-income countries. According to published research from Switzerland, "The '3 by 5' goal to have 3 million...

GLIADEL Wafer assigned new DRG designation.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals, Inc., (GLFD) announced that GLIADEL Wafer (polifeprosan 20 with carmustine implant), the company's proprietary brain cancer treatment, has been assigned to a new Diagnosis...

Japan gives Cambodia nearly US$25 million for healthcare.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Japan said August 11, 2004, it will give Cambodia nearly US$25 million to help eradicate land mines and improve healthcare in the impoverished Southeast Asian nation. Cambodian Foreign Minister Hor...

Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Scientists report the seroprevalence of markers of viral hepatitis in Yemeni healthcare workers in a recent issue of the Journal of Medical Virology. "The seroprevalence of viral hepatitis in...

Trial finds effective treatment for testosterone replacement.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories, Inc., (NASDAQ:CBRX) announced that results of a Phase III study demonstrate that Striant (testosterone buccal system) (CIII) 30 mg is a safe and effective treatment for...

Feds say "club drug"-related visits to ERs show some sharp declines.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Emergency room visits related to "club drugs" - GHB, Ketamine, LSD, and Ecstasy - remained stable or headed downward in 2002, according to a new report for the Substance Abuse and Mental Health Services...

VIG product submitted for FDA approval.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Cangene announced that it has submitted a biological license application (BLA) to the U.S. Food and Drug Administration (FDA) for Cangene's Vaccinia hyperimmune globulin (VIG). Cangene's...

Human B cells are alternative source of efficient antigen-presenting cells.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection are an alternative source of efficient antigen-presenting cells. "Dendritic cells (DCs) are the most...

Day of week and collection length vital to nosocomial infection surveys.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Day of the week and duration of data collection are important factors in prevalence surveys of nosocomial infections. According to recent research from Spain, "In a national prevalence survey...

Rodent prey reduce reservoirs of transmissible pathogens.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Rodent prey reduce the reservoirs of transmissible pathogens. According to published research from the United States, "Zoonotic diseases, caused by pathogens transmitted to people from vertebrate...

CDC: Flu shot effective more than half of the time.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Last season's influenza vaccine was effective more than half the time, despite fears the shot was not an exact match for the flu strain that dominated the United States, the government says. A...

Company delivers first million doses of Fluvirin vaccine to U.S. distributors.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) announced it has delivered the first 1 million doses of its Fluvirin influenza vaccine to U.S. distributors in preparation for the upcoming influenza season. The company expects...

First influenza vaccine shipped to healthcare providers.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Aventis has started shipment of its influenza vaccine (Fluzone, Influenza Virus Vaccine), meeting the company's goal to provide Fluzone vaccine to customers to allow healthcare providers to plan...

Influenza causes excess hospital admissions in Hong Kong.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Influenza season results in excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure in Hong Kong. "It is widely held that Southern China is a hypothetical...

CDC: Animals cause more than 26,000 roadway injuries each year.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Deer, cows and even squirrels are to blame for more than 26,000 injuries along the nation's roads each year, the U.S. government says. It is the first time the U.S. Centers for Disease Control and...

Action in Afghanistan aims to control debilitating disease.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A rapid intervention by the World Health Organization (WHO) and its partners, the Massoud Foundation and HealthNet International, in Kabul, Afghanistan, made possible by a donation from the Belgian...

Cell loading system used in phase I/II gene therapy trial for leukemia.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- MaxCyte, Inc., announced its MaxCyte GT cell loading system is being used in a phase I/II clinical trial sponsored by the Center for Cell and Gene Therapy at Baylor College of Medicine and The Methodist...

Lyme borreliosis from infection to autoimmunity reviewed.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Lyme borreliosis, from infection to autoimmunity, is reviewed in a recent issue of Clinical Microbiology and Infection. "Lyme borreliosis in humans is an inflammatory disease affecting multiple...

Fever temperature linked to malaria infectivity rate.
September 5, 2004... 2004 SEP 5 - (NewsRx.com & NewsRx.net) -- Fever temperature is inversely associated with malaria infectivity rate. "A retrospective examination was made of archival data collected between 1940 and 1963 on the infection of mosquitoes with...